Vivos Therapeutics, Inc. (VVOS) Earnings Call Analysis
NASDAQ · Healthcare · Medical Devices
Earnings Reports
-
Vivos Therapeutics (VVOS) Q1 2026: Revenue Jumps 70% as Sleep Center Pivot Drives Patient Growth
May 21, 2026
-
Vivos (VVOS) Q4 2025: SCN Acquisition Adds $8M in New Model Revenue, Shifts Growth Trajectory
April 16, 2026
-
Vivos (VVOS) Q3 2025: SCN Acquisition Drives 76% Revenue Surge, Validates Direct Sleep Practice Model
November 20, 2025
-
Vivos (VVOS) Q2 2025: SO Teams Model Drives 27% Sequential Revenue Growth Amid Transition
August 20, 2025